about
Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaVaccine Treatment for Surgically Resected Pancreatic CancerPilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSLCellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the LungGVAX in Advanced Prostate Cancer Patients Made LymphopenicThe Development of Human Immunologic Assays Specific to Folate Receptor AntigenSurvivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical CancerAllogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerImmunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate CancerFluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal CancerCarboxyamidotriazole in Treating Patients With Advanced Kidney CancerVaccine Therapy in Treating Patients With Metastatic Prostate CancerBiological Therapy in Treating Patients With Glioblastoma MultiformeBiological Therapy in Treating Patients With Primary or Advanced GliomaVaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic CancerMonoclonal Antibody Therapy in Treating Patients With Brain MetastasesFluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By SurgeryVaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV MelanomaRadiolabeled Monoclonal Antibody in Treating Patients With Advanced Colorectal CancerMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsMonoclonal Antibody Therapy in Treating Patients With Recurrent GliomasOndansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer TreatmentImmunotherapy in Treating Patients With Metastatic Breast CancerBiological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or OligodendrogliomaCombination Chemotherapy in Treating Patients With Advanced Colorectal CancerBiological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Advanced Breast CancerCultured White Cells Plus Interleukin-2 to Treat Advanced Kidney CancerAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerPROvenge Treatment and Early Cancer TreatmentPhase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal SeedingCombination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast CancerDenileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerNatural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney CancerGemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerVaccine Treatment for Hormone Refractory Prostate CancerVaccine Therapy in Treating Patients With Advanced or Metastatic CancerCyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerVaccine Treatment of Kidney CancerTrial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate CancerCetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery
P8363
Q57774323-FB4F6CB7-C5B7-4E14-9238-B6163212A107Q58391323-BDF002C4-D01B-47AC-B3AA-7DD91C3048B1Q58393690-F1E214FA-8395-43B1-9BEB-1A625A5D275CQ58402915-17551612-067A-4B4C-9213-D56573DC60C1Q58405893-BEB0EE21-1071-422E-B077-6F973882A02BQ58406139-3809FE9C-37C2-4BCB-A2A5-D314739C9627Q58407025-1264688B-2BAD-4526-B42B-6724B225AFB8Q58407098-E29678C4-B85E-4C25-8E65-49AB6AE725D0Q58407099-6E3898CC-81DC-4CDB-AF30-715B513AF1B5Q58407311-BE6EF7D5-C9AA-455D-BFB3-97D6CE5423BCQ58407313-841CF3BA-DE83-4524-B82C-1E003310C3B2Q58407314-429B87FA-9625-41B7-A1F8-9F9225BEC9E5Q58407315-1AC8A5F0-AF14-4D41-804B-B697B5C50100Q58407318-8BDDDAB1-050A-4153-A719-AA4D2929ED34Q58407319-7A7DDD8D-5BAC-432C-8BC0-DF320F02ECA0Q58407322-B7722482-7AAB-4C3B-9AA2-1A5D09414C8CQ58407323-9311A41B-67C0-427D-8BB6-9EBD3D47C116Q58407324-743431B1-832C-4B28-B5EF-282E8653F833Q58407325-1D7718F8-46A1-4F04-9354-896AFCDE9C48Q58407326-97579681-0308-4FC1-86CD-D97E3B564518Q58407328-35A6ED4E-C710-446D-B605-B572FE55FD64Q58407329-BE69DCC2-7AB1-4EF9-A6B9-F753AC14A0ADQ58407330-068673C5-3A22-4390-BA6B-5AD064AF6630Q58407402-E7B64768-FC9D-45DE-BFCC-CEAE0F316DBCQ58407403-E8577694-3E4F-4B3C-B130-B08488D22730Q58407405-33DB12C3-22C8-42F2-BFFF-82F6F9854EB2Q58407406-9238BB20-0F5E-465B-9D82-627055832D21Q58407407-106F4B73-C747-4FC8-964C-29B0806A579FQ58407408-58CD72E7-B1AE-4D32-9D49-586FFB682DA4Q58407411-ED5D55C4-0186-48C0-B10D-587AE7084D29Q58407412-AD82A88A-458B-46C7-9FFC-609764B3DE29Q58407413-38410E47-426F-4BDB-AC1A-E0C571457292Q58407427-6C46AF4F-BB8D-42AC-8E47-29DB23B92915Q58407428-CDF1D943-D960-4A25-B5EA-FCB3C03F001CQ58407430-2C180913-CF8E-4853-B58C-E7AC329734A5Q58407432-4F9A40C3-0334-4D7B-9459-38116FE37A02Q58407433-91D1E271-8BE4-44B4-9F7E-C93AF26335A9Q58407435-9068DF9F-C328-470D-A969-E5B8A70AAB04Q58407436-71F85D6B-2896-4776-AFC9-822C3F8C126CQ58407437-A50A7402-FDC3-4BD0-AF7A-92295E9898ED
P8363
description
research project which changes participants
@en
name
estudi intervencional
@ca
interventiestudie
@nl
interventional study
@en
type
label
estudi intervencional
@ca
interventiestudie
@nl
interventional study
@en
altLabel
clinical study
@en
human subject research
@en
prefLabel
estudi intervencional
@ca
interventiestudie
@nl
interventional study
@en